Dr Matteo Puccetti is a Senior Researcher in a tenure-track position, with qualification for Associate Professor, at the Department of Pharmaceutical Sciences, University of Perugia. His work focuses on drug delivery technologies for rare diseases, with particular attention to pulmonary and gastrointestinal targeting, anti-inflammatory therapies, drug discovery from the microbiota, and microbial pharmaceutics.
He obtained his PhD in Pharmaceutical Sciences from the University of Perugia, with a thesis on new delivery strategies of indole-3-aldehyde for gastrointestinal and pulmonary diseases. He also holds a degree in Pharmacy, a Master’s degree in Medical, Veterinary and Forensic Biotechnological Sciences, and qualification to practise as a pharmacist. His previous appointments include research positions at the University of Perugia, a fellowship supported by the Italian Cystic Fibrosis Research Foundation, and an international doctoral fellowship at the Woolcock Institute of Medical Research, University of Sydney.
His research integrates pharmaceutical technology, targeted drug delivery, postbiotic metabolites, cystic fibrosis, pulmonary inflammation, and microbiota-derived therapeutics. He has authored more than 50 peer-reviewed publications, holds patents in inhalable pharmaceutical compositions, received a Young Researcher Award, and serves in editorial, teaching, and university committee roles.
